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Usual Interstitial Pneumonia and
Non-Specific Interstitial Pneumonia:
Serial Thin-Section CT Findings
Correlated with Pulmonary Function
Objective: We wanted to demonstrate and compare the serial high-resolution
CTs (HRCT) and the pulmonary function test (PFT) findings of the usual intersti-
tial pneumonia (UIP) and the non-specific interstitial pneumonia (NSIP).
Materials and Methods: The serial HRCT scans and the PFT results were ret-
rospectively analysed and compared for 35 patients having UIP without signifi-
cant honeycombing (UIP-w/o hc, < 5% of honeycombing at CT), 35 patients hav-
ing UIP with honeycombing (UIP-w/i hc,  5% of honeycombing), and 25
patients with NSIP. The mortality rates were also compared. Follow-up CT scans
were available in 75 patients (29 UIP-w/o hc patients, 22 UIP-w/i hc patients and
24 NSIP patients) and the follow-up periods ranged from 150 to 2,370 days. The
initial and follow-up PFT data were available for 71 patients.
Results: On the initial CT, significant differences were present between the
UIP-w/i hc patients and both the UIP-w/o hc patients and the NSIP patients in the
overall extent, ground-glass opacity (GGO) away from the reticulation, reticulation
and honeycombing (all p < 0.05). Improvement was noticed in five (17%) of 29
UIP-w/o hc patients, none of 22 UIP-w/i hc patients, and 9 (37%) of 24 NSIP
patients; deterioration was noted in six (21%) UIP-w/o hc patients, two (9%) UIP-
w/i hc patients and three (13%) NSIP patients (p = 0.044 between UIP-w/o and
UIP-w/i hc; p = 0.637 between UIP-w/o hc and NSIP; p = 0.007 between UIP-w/i
hc and NSIP). The serial changes of the pulmonary function in the NSIP patients
were different from those noted for the UIP-w/i hc and UIP-w/o hc patients (p =
0.440 between UIP-w/o and UIP-w/i hc; p = 0.022 between UIP-w/o hc and NSIP;
p = 0.003 between UIP-w/i hc and NSIP). Five (14%) of the 35 patients with UIP-
w/o hc, 16 (46%) of the 35 patients with UIP-w/i hc and three (12%) of the 25
patients with NSIP died (p = 0.002, comparison for the three groups).
Conclusion: On CT, NSIP and UIP-w/o hc patients have similar patterns of
parenchymal abnormalities and a similar likelihood of change in the extent of dis-
ease on follow-up. Patients with UIP-w/i hc have distinctive features and a worst
prognosis.
igh-resolution CT (HRCT) plays an important role for the diagnosis and
management of patients with idiopathic interstitial pneumonia (1 4).
However, the ability of HRCT to distinguish usual interstitial pneumonia
(UIP) and non-specific interstitial pneumonia (NSIP), the two largest subsets of
idiopathic interstitial pneumonias, is controversial because there is considerable
overlap in CT findings for these maladies (3, 5, 6). This distinction is important
because NSIP is known to show a better prognosis than UIP (7 9).
It has been reported that there is a difference in survival between those patients
having the HRCT findings typical of UIP (extensive subpleural honeycombing, reticu-
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Hlation and minimal ground-glass opacity) and those
patients without these typical features (10). The extent of
honeycombing of the lung on HRCT is small (around 5%)
in the patients surviving UIP (11), and this is the most
probable or definite diagnostic indicator of the disease (10,
12), and the honeycombing is progressive in extent on the
follow-up studies even with low-dose corticosteroid
treatment (13). Therefore, patients with UIP may be
subdivided into those patients having UIP without signifi-
cant honeycombing (UIP-w/o hc; < 5% of honeycombing
at CT) and those patients having UIP with honeycombing
(UIP-w/i hc;  5% of honeycombing).
The differences in the CT patterns and for survival that
are observed for the same interstitial lung disease entity in
different series or from different institutions might be
explained by the differences in the homogeneity of the
patient population included. The aim of the current study
was to demonstrate the initial and serial CT findings of the
pathologically proven UIP and NSIP patients seen at a
single institution, and these findings were correlated with
the serial pulmonary function changes.
MATERIALS AND METHODS
Patients and Histopathologic Diagnosis
All the open and thoracoscopic lung biopsy diagnoses for
the cases of idiopathic interstitial pneumonias seen in a
single tertiary hospital over a nine-year period (November
1994 - October 2003) were searched for by conducting a
review of the computer records. One hundred and twenty-
eight patients with idiopathic interstitial pneumonias were
identified. Two independent experienced lung pathologists
(one with 13 years of experience from our hospital and the
other with 27 years of experience from another hospital),
who were blinded to the clinical and radiological features,
retrospectively reviewed all the pathologic specimens from
these patients. The pathologic specimens were obtained by
video-assisted thoracoscopic surgery (VATS) (n=89), open
lung biopsy (n=36), and lobectomy (n=3). Of the 128
patients, 29 patients were diagnosed to have idiopathic
interstitial pneumonias other than UIP or NSIP. Therefore,
we excluded these 29 patients from the study. Of the
remaining 99 patients, three was regarded to have
radiologically and clinically overt acute exacerbations of
the usual interstitial pneumonias and one was regarded to
have mixed Pneumocystis carinii and cytomegalovirus
pneumonias. These four patients were also excluded from
the study. We included the remaining 95 patients who
were diagnosed as having had UIP or NSIP by one or two
of the lung pathologists. When the two pathologists had a
different opinion (n=9) regarding the diagnosis of UIP or
NSIP, an experienced chest physician with 13 years of
experience made the final diagnosis in consideration of all
available clinical, radiological and histopathologic data.
Clinical Features and Pulmonary Function Test
Clinical data were obtained by reviewing the patients’
hospital records. These records included the duration and
nature of the symptoms, the initial and follow-up PFT
findings, the treatment regimens and the number and
causes of death. The mean interval between the onset of
clinical symptoms and the initial CT was 15 months (SD
[standard deviation]; 25 months, range; 10 days to 120
months). The presenting symptoms included dyspnea in 39
patients (41%), cough in 32 (34%), cough and dyspnea in
16 (17%), chest pain in four (4%), fever in one (1%), and
blood tinged sputum in one (1%). The remaining two (2%)
patients were asymptomatic. The mean time interval
between lung biopsy and the initial CT examination was
18 days (median; 9 days, range; 0 to 300 days). In 89
(94%) of 95 patients, the CT was performed within 60
days of biopsy. In the remaining six patients, the CT was
performed within 60 300 days of biopsy. CT was
performed before biopsy in 91 (95%) patients and it was
obtained after biopsy in four patients.
All of the patients received no treatment before the
initial CT scan. During the follow-up period between their
CT scans, 47 (49%) patients received cyclosphosphamide
therapy with or without corticosteroids, 24 (25%) received
interferon-gamma with or without cyclosphosphamide or
corticosteroids, nine (10%) received parenteral or oral
corticosteroids alone, and 15 (16%) received no treatment. 
The initial and follow-up pulmonary function test (PFT)
data were available for 71 (75%) of 95 patients. Forced
spirometry and the single-breath carbon monoxide diffus-
ing capacity of the lung (DLCO) were obtained with
pulmonary function units (SensorMedics Corporation,
Yorba Linda, CA, USA). The forced vital capacity (FVC)
and DLCO were expressed as a percentage of the predicted
value based on the patients’ height, age, gender and ethnic
origin.
CT Interpretation
The initial HRCT scans were available for all 95 patients.
The follow-up CT scans, regardless of the patients’ final
outcome (death), were available for 75 (79%) of 95
patients. These included all five of the deceased UIP-w/o
hc patients, eight of the 16 deceased UIP-w/i hc patients,
and two of the three deceased NSIP patients. In these
deceased patients, the last CT scans obtained prior to the
acute exacerbation of pulmonary fibrosis or prior to the
appearance of the pulmonary lesions that led to the
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between the initial and follow-up CTs were 711 days (SD;
551, range; 210 2,220 days) in the UIP-w/o hc patients,
484 days (SD; 366, range; 150 1,440 days) in the UIP-w/i
hc patients, and 939 days (SD; 703, range; 150 2,370
days) in the NSIP patients, respectively.
The HRCT scans were performed using 1-mm collima-
tion at 10-mm intervals from the lung apices to the lung
bases at the end of inspiration. The images were
reconstructed using a high spatial frequency algorithm and
they were photographed on the lung window (window
width; 1,500 H, level;  700 H). Two experienced chest
radiologists (with two years and six years of experience,
respectively), who were unaware of the clinical, lung
function or pathological data, independently analyzed the
CT images.
The observers made a subjective assessment of the
overall extent of the pulmonary parenchymal abnormality
as well as the extent of the consolidation, the total extent
of the ground-glass opacity (GGO), the extent of the GGO
away from the reticulation, reticulation, honeycombing
and nodular opacities. Consolidation was considered
present when the opacity obscured the underlying vessels.
GGO was defined as an area of hazy increased attenuation
without obscuration of the underlying vascular markings.
Reticulation was defined as the innumerable, interlacing
lines suggesting a mesh. Honeycombing was regarded as
present when clustered cystic airspaces 3 10 mm in
diameter with shared well-defined walls were identified
with layering in the subpleural lungs. The extent of the
parenchymal abnormality was scored to the nearest 5%;
when less than 10% of the lung was involved, an estimate
to the nearest 1% was recorded. The overall symmetry
and distribution of the parenchymal abnormalities both in
the transverse (central, peripheral, diffuse or random) and
longitudinal planes (upper zone, lower zone, random or
diffuse) were recorded. The two independent observers
who initially analyzed the images from the first HRCT
study were blinded to the follow-up scans. Next, the two
independent observers simultaneously viewed the initial
and follow-up HRCT images of each patient and they
scored the overall extent and distribution of the CT
abnormalities and the extent of each CT pattern on the
follow-up study. These data were used to calculate the
interobserver agreement and the data were used in the
comparisons outlined below. Finally, a consensus reading
was performed between the two observers and a third
experienced chest radiologist (with 15 years of experi-
ence), in the cases where there was a discrepancy between
the two observers regarding the presence or absence of
individual CT patterns. These data were used solely for
descriptive purposes.
Data Analysis
Interobserver variations in the specific diagnoses of
idiopathic interstitial pneumonias and in distinguishing
NSIP from UIP between the two lung pathologists were
calculated using Kappa statistics.
The number of the deceased patients and the causes of
death during the follow-up period were described and
compared for the three groups, namely, the patients in
UIP-w/o hc, the patients in UIP-w/i hc and the patients in
NSIP. Statistical differences of the mortality rates during
the follow-up period for the three different groups of
interstitial pneumonia were tested for by performing Chi-
square testing followed by Fisher’s exact test with using the
permutation method for multiple testing. The inter-
observer agreement for the overall extent and presence of
irregular linear opacity, honeycombing, GGO, GGO away
from the reticulation, reticulation and consolidation was
analyzed by calculating the intra-class correlation coeffi-
cient.
The means of both observers for the overall extent of
disease and for each CT pattern were calculated for the
initial and the follow-up studies. A change in the overall
disease extent of 10% or greater was considered to
represent disease regression or progression, while a change
of less than 10% was considered insignificant and within
experimental error. We correlated the changes in the
extent of each parenchymal and total abnormality and the
changes in the extent of the pulmonary function by using
Spearman’s correlation analysis.
Statistical differences for the presence of and the extent
of the various patterns of parenchymal abnormalities for
the three different groups were analyzed by using Kruskal-
Wallis test or by one-way analysis of variance (ANOVA),
and by using the least significant difference test for
multiple comparisons. The statistical differences for the
inter-scan HRCT changes and the pulmonary function of
the three different groups were tested for by Fisher’s exact
test with using the permutation method and Bonferroni’s
correction for multiple testing. In all the statistical analyses,
p values less than 0.05 were regarded as significant.
RESULTS
The diagnostic agreement between the two lung patholo-
gists for the diagnosis of UIP and NSIP was 91% (86 of 95
cases) (kappa score, 0.76). Of the 95 patients included in
the study, 35 patients (37%) had UIP-w/o hc, 35 patients
(37%) had UIP-w/i hc and 25 patients (26%) had NSIP.
During the follow-up period, five patients (14%) of the 35
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hc patients, and three patients (12%) of the 25 NSIP
patients died (p = 0.002, comparison for the three groups
was done using Chi-square testing followed by
Bonferroni’s correction, Table 1). The mortality rates of
the patients with UIP-w/i hc were significantly different
from those of the patients with UIP-w/o hc (p = 0.014) or
NSIP (p = 0.016). However, the mortality rates were not
significantly different between the patients with UIP-w/o
hc and the patients with NSIP (p = 1.000). The causes of
death in the five UIP-w/o hc patients were acute exacerba-
tion of pulmonary fibrosis per se in four and lung cancer in
one; the causes of death in the 16 UIP-w/i hc patients were
acute exacerbation of pulmonary fibrosis per se in 10,
Jeong et al.
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Table 1. Interobserver Agreements for the Mean Extent of
Each Parenchymal Abnormality at the Initial High-
Resolution CT
Parenchymal
Intra-class  95% CI for Intra-
Abnormality
Correlation class Correlation
Coefficient Coefficient
Overall 0.956 (0.940, 0.969)
GGO 0.920 (0.892, 0.943)
GGO away from reticulation 0.177 (0.056, 0.306)
Consolidation 0.757 (0.683, 0.819)
Reticulation 0.519 (0.407, 0.624)
Honeycombing 0.784 (0.716, 0.840)
Nodular opacity 0.699 (0.613, 0.774)
Note. GGO = ground-glass opacity
AB
Fig. 1. Usual interstitial pneumonia without significant honeycombing in a 54-year-old man.
A, B. Lung window of the transaxial high-resolution (1.0-mm collimation) CT scans obtained at the levels of the inferior pulmonary vein
(A) and the liver dome (B), respectively, show patchy ground-glass opacity, reticulation, and a little honeycombing in the subpleural
areas and in the posterior aspect of both lower lobes (total extent; 34% of the lung volume, ground-glass opacity; 24%, reticulation; 8%,
honeycombing; 2%).
C, D. CT scans obtained at similar levels to A and B and at four and half years later show the decreased extent of the overall parenchy-
mal abnormalities, but the increased extent of honeycombing and reticulation (total extent; 24% of the lung volume, ground-glass opacity;
7%, reticulation; 11%, honeycombing; 6%).
CDpneumonia in three, lung cancer in two and adult respira-
tory distress syndrome triggered by interferon-gamma
treatment in one; the causes of death in the three NSIP
patients were sepsis, wound infection and lymphoma,
respectively.
Initial HRCT Findings
There was fair to good agreement between the observers
for the extent of parenchymal abnormalities except for the
GGO away from the reticulation (Table 1). On the initial
CT, GGO, GGO away from the reticulation, reticulation,
honeycombing, consolidation and nodular opacities were
present in 35 (100%), 12 (34%), 35 (100%), 22 (63%),
seven (20%), and two (6%) of the 35 UIP-w/o hc patients
(Fig. 1); in 35 (100%), four (11%), 35 (100%), 35 (100%),
six (17%), and one (3%) of the 35 UIP-w/i hc patients (Fig.
2); and in 25 (100%), 12 (48%), 23 (92%), 11 (44%), nine
(36%), and three (12%) of the 25 NSIP patients (Fig. 3),
respectively. The abnormalities were symmetrical in all the
patients. On the transaxial plane, the distribution of the
abnormalities was predominantly subpleural in 33 (94%)
of the 35 UIP-w/o hc patients, in 34 (97%) of the 35 UIP-
w/i hc patients and in 22 (88%) of the 25 NSIP patients;
the distribution of the abnormalities were random in one
(3%) of the 35 UIP-w/o hc patients, zero (0%) of the 35
UIP-w/i hc patients, and one (4%) of the 25 NSIP patients;
and the distribution of the abnormalities was diffuse in one
(3%) of the 35 UIP-w/o hc patients, in one (3%) of the 35
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AB
Fig. 2. Usual interstitial pneumonia with honeycombing in a 63-year-old man. 
A, B. Lung window of transaxial hiph-resolution (1.0-mm collimation) CT scans obtained at the levels of inferior pulmonary vein (A) and
the liver dome (B), respectively, show patchy ground-glass opacity, reticulation and honeycombing in the subpleural area and in the
posterior aspect of both lower lobes (total extent; 27% of lung volume, ground-glass opacity; 10%, reticulation; 5%, honeycombing;
12%).
C, D. CT scans obtained at similar levels to A and B and four years later show little change in extent of the parenchymal abnormalities
(total extent; 30% of lung volume, ground-glass opacity; 10%, reticulation; 5%, honeycombing; 15%).
CDUIP-w/i hc patients, and in two (8%) of the 25 NSIP
patients. On the cephalo-caudal plane, the lesions were
predominantly in the lower zone in 25 (71%) of the 35
UIP-w/o hc patients, in 27 (77%) of the 35 UIP-w/i hc
patients and in 21 (84%) of 25 NSIP patients; the lesions
were random in nine (26%) of the 35 UIP-w/o hc patients,
in seven (20%) of the 35 UIP-w/i hc patients, and in three
(12%) of 25 NSIP patients; and the lesions were diffuse in
one (3%) of the 35 UIP-w/o hc patients, in one (3%) of the
35 UIP-w/i hc patients, and in one (4%) of the 25 NSIP
patients.
The mean extents of the overall lung abnormality, GGO,
GGO away from the reticulation, reticulation, honeycomb-
ing, consolidation and nodular opacities were 27%, 17%,
2%, 8%, 2%, 1% and 0% in the UIP-w/o hc patients;
43%, 19%, 0%, 11%, 13%, 0% and 0% in the UIP-w/i hc
patients; and 33%, 20%, 3%, 9%, 2%, 3% and 0% in the
NSIP patients, respectively (Table 2). The mean extents of
overall lung abnormality, GGO away from the reticulation,
reticulation and honeycombing of UIP-w/i hc patients were
Jeong et al.
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AB
Fig. 3. Non-specific interstitial pneumonia in a 73-year-old woman.
A, B. Lung window of the transaxial hiph-resolution (1.0-mm collimation) CT scans obtained at the levels of the inferior pulmonary vein
(A) and the liver dome (B), respectively, show extensive patchy ground-glass opacity, consolidation and reticulation in both lungs (total
extent; 45% of lung volume, ground-glass opacity; 30%, consolidation; 7%, reticulation; 8%). Also note the traction bronchiectasis
(arrows).
C, D. CT scans obtained at similar levels to A and B and five years later show the decreased extent of the parenchymal abnormalities
(total extent; 20% of lung volume, ground-glass opacity; 12%, reticulation; 8%).
CDsignificantly different from those of the patients with UIP-
w/o hc or NSIP (Tables 2, 3). However, the mean extent of
each parenchymal abnormality was not significantly differ-
ent between the patients with UIP-w/o hc and the patients
with NSIP (Tables 2, 3).
Follow-up HRCT Findings
At the follow-up CT, the mean ( SD) overall extent of
abnormal lung parenchyma was 26% ( 16%) in the UIP-
w/o hc patients, 44% ( 18%) in the UIP-w/i hc patients,
and 24% ( 11%) in the NSIP patients. The distribution
of the parenchymal abnormalities was similar to those seen
at the initial CT. The mean extent of GGO, GGO away
from the reticulation, reticulation, honeycombing, consoli-
dation and nodular opacities at the follow-up CT were
13%, 0%, 10%, 2%, 1% and 0% in the UIP-w/o hc
Serial Thin-Section CT Findings of UIP and NSIP Correlated with Pulmonary Function
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Table 2. The Mean Extent of Parenchymal Abnormalities at the Initial High-Resolution CT
Parenchymal abnormality Group N Mean Median SD Range Inter-quartile range p-value
Overall UIP-w/o hc 35 27 27.0 15.9 0(5, 77) (17, 35) < 0.001
UIP-w/i hc  35 43 42.0 17.6 (15, 95) (32.0, 50.0)
NSIP 25 33 30.0 17.7 0(8, 93) (20, 40)
GGO UIP-w/o hc 35 17 13.0 14.6 0(2, 67) 0(8, 22) 0.436
UIP-w/i hc 35 19 15.0 13.3 0(6, 77) (10.0, 22.0)
NSIP 25 20 17.0 13.2 0(5, 60) (10, 25)
GGO away from reticulation UIP-w/o hc 35 02006.0 0(0, 27) (0, 1) 0.004
UIP-w/i hc 35 00000.6 (0, 3) (0, 0)
NSIP 25 03006.4 0(0, 28) (0, 3)
Consolidation UIP-w/o hc 35 01001.7 (0, 7) (0, 0) 0.082
UIP-w/i hc 35 00001.0 (0, 5) (0, 0)
NSIP 25 03004.4 0(0, 18) (0, 5)
Reticulation   UIP-w/o hc 35 08 08.0 03.7 0(1, 15) 0(5, 10) 0.004
UIP-w/i hc 35 11 11.0 04.5 0(3, 23) 0(8, 13)
NSIP 25 09 08.0 04.7 0(0, 20) 0(7, 12)
Honeycombing UIP-w/o hc 35 02201.4 (0, 4) (0, 2) < 0.001
UIP-w/i hc 35 13 110. 07.3 0(5, 30) 0(7, 17)
NSIP 25 02002.7 0(0, 10) (0, 3)
Nodular opacity UIP-w/o hc 35 00000.4 (0, 2) (0, 0) 0.338
UIP-w/i hc 35 00000.2 (0, 1) (0, 0)
NSIP 25 00000.6 (0, 2) (0, 0)
Note. Kruskal-Wallis test,    ANOVA test, NSIP = non-specific interstitial pneumonia, UIP-w/o hc = usual interstitial pneumonia without significant
honeycombing, UIP-w/i hc = usual interstitial pneumonia with honeycombing, GGO = ground-glass opacity, N = number of patients, SD = standard
deviation
Table 3. Statistical Differences of the Mean Extent of
Parenchymal Abnormalities at the Initial CT in Three
Different Groups of Interstitial Pneumonia
Parenchymal UIP-w/o hc UIP-w/o hc UIP-w/i hc
Abnormality vs. UIP-w/i hc vs. NSIP vs. NSIP
Overall p < 0.001 p = 0.143 p = 0.009
GGO away from reticulation p = 0.034 p = 0.154 p = 0.001
Reticulation    p = 0.001 p = 0.249 p = 0.056
Honeycombing p < 0.001 p = 0.697 p < 0.001
Note. The least significant difference test using ranks for multiple
comparisons,    The least significant difference test for multiple
comparisons, GGO = ground-glass opacity, NSIP = non-specific interstitial
pneumonia, UIP-w/o hc = usual interstitial pneumonia without significant
honeycombing, UIP-w/i hc = usual interstitial pneumonia with
honeycombing
Table 4. Statistical Differences of the Inter-scan Changes of
the Parenchymal Abnormalities in the Three
Different Groups of Interstitial Pneumonia
Inter-scan  UIP-w/o hc  UIP-w/o hc UIP-w/i hc
Changes vs. UIP-w/i hc vs. NSIP vs. NSIP
Changeable-Stable p = 0.044 p = 0.637 p = 0.007
Improvement-Stable p = 0.167 p = 0.937 p = 0.004
Improvement-Deterioration p = 1.000 p = 1.000 p = 0.392
Stable-Deterioration p = 0.854 p = 1.000 p = 1.000
Note. Changeable = Improvement or deterioration, Improvement = 
10% reduction, Deterioration =  10% increase, Stable = less than 10%
of inter-scan changes, NSIP = non-specific interstitial pneumonia, UIP-w/o
hc = usual interstitial pneumonia without significant honeycombing, UIP-
w/i hc = usual interstitial pneumonia with honeycombingpatienta; 18%, 1%, 13%, 13%, 1% and 0% in the UIP-
w/i hc patients; and 13%, 0%, 9%, 2%, 0% and 0% in the
NSIP patients, respectively.
Inter-scan Changes
There was an improvement ( 10% reduction) in the
overall disease extent in five (17%) of the 29 UIP-w/o hc
patients (Fig. 1), zero (0%) of the 22 UIP-w/i hc patients
and nine (37%) of the 24 NSIP patients (Fig. 3); a deterio-
ration ( 10% increase) of the disease extent was noted in
six (21%) of the UIP-w/o hc patients, in two (9%) of the
UIP-w/i hc patients and in three (13%) of the NSIP
patients. The observed changes were less than 10% in the
remaining 18 (62%) UIP-w/o hc patients, in 20 (91%) of
the UIP-w/i hc patients (Fig. 2), and in 12 (50%) of the
NSIP patients. A statistically significant difference of the
inter-scan changes was observed in the three different
groups (p = 0.044 between the UIP-w/o and UIP-w/i hc
patients, p = 0.637 between the UIP-w/o hc and NSIP
patients, p = 0.007 between the UIP-w/i hc and NSIP
patients, with employing Fisher’s exact test and using the
permutation method and Bonferroni’s correction for
multiple testing, Table 4).
Overall, the mean ( SD) absolute change in the extent
of the total GGO, GGO away from the reticulation, reticu-
lation, honeycombing, consolidation and nodule in UIP-
w/o hc patients was  5% (18%),  2% (7%), 2% (4%),
1% (2%), 0% (2%), and 0% (0%), where a negative
change indicates a reduction. Overall, the mean ( SD)
absolute change in the extent of the total GGO, GGO
away from the reticulation, reticulation, honeycombing,
consolidation and nodule was 2% (7%), 1% (4%), 1%
(2%), 0% (3%), 0% (2%), and 0% (0%) in the 22 UIP-w/i
hc patients and   5% (10%),  2% (6%), 1% (4%), 0%
(3%),  2% (4%), and 0% (1%) in the 24 NSIP patients,
respectively.
Relationship between the Initial HRCT Pattern and
the Changes in Pulmonary Function
The initial and follow-up PFT data were available in 71
patients (23 NSIP, 28 UIP-w/o hc and 20 UIP-w/i hc
patients). There was an improvement ( 15% reduction)
for the pulmonary function in four (14%) of the 28 UIP-
w/o hc patients, in zero (0%) of the 20 UIP-w/i hc patients
and in nine (39%) of the 23 NSIP patients; there was a
deterioration ( 15% increase) in two (7%) of the UIP-
w/o hc patients, in two (10%) of the UIP-w/i hc patients
and in three (13%) of the NSIP patients. The observed
changes were less than 15% in the remaining 22 (79%)
UIP-w/o hc patients, in the remaining 18 (90%) UIP-w/i hc
patients and in the remaining 11 (48%) NSIP patients. The
serial changes of the pulmonary function in the NSIP
patients were different from those in UIP-w/i hc and UIP-
w/o hc patients (p = 0.440 between the UIP-w/o and UIP-
w/i hc patients; p = 0.022 between the UIP-w/o hc and
NSIP patients; p = 0.003 between the UIP-w/i hc and NSIP
patients).
The change in the overall extent, GGO, reticulation,
GGO away from the reticulation and consolidation of the
parenchymal abnormalities on the HRCT showed
moderate correlation with the changes in FVC, but only
the change in extent of reticulation correlated with the
change in the DLCO (Table 5).
DISCUSSION
The initial reports on the HRCT features of NSIP
suggested there was a characteristic pattern consisting of
patchy bilateral, predominantly middle- and lower-zone
predominant GGO with or without consolidation or reticu-
lation, and the absence or the rarity of honeycombing (14,
15). Contrary to the relatively homogenous descriptions in
these initial reports, Hartman et al. (5), in a study of 50
patients with biopsy-proven NSIP, reported a much
broader spectrum of HRCT findings. In their series, only
22% of the patients had HRCT findings compatible with
the previous descriptions of NSIP, while 32% of the
patients’ findings were considered more typical of UIP and
the remainder were considered as either non-diagnostic or
more compatible with other chronic infiltrative lung
diseases. MacDonald et al. (6) also reported a considerable
overlap between the CT findings of NSIP and those of
UIP. In our study, we demonstrated that while UIP-w/i hc
had the characteristic HRCT findings, the manifestations of
UIP-w/o hc were similar to those of NSIP.
Previous studies have reported that the areas of GGO in
Jeong et al.
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Table 5. Correlation between the Changes in the Extent of
Parenchymal Abnormality and the Changes in the
Extent of Pulmonary Function
Parenchymal Forced Vital  Diffusing Capacity 
Abnormality Capacity of the Lung
Overall r =  0.723, p < 0.001 r =  0.236, p = 0.051
GGO r =  0.718, p < 0.001 r =  0.196, p = 0.107
GGO away from r =  0.401, p = 0.001 r =  0.016, p = 0.896
reticulation
Consolidation r =  0.395, p = 0.001 r =  0.045, p = 0.713
Reticulation r =  0.514, p < 0.001 r =  0.262, p = 0.029
Honeycombing r =  0.188, p = 0.122 r =  0.209, p = 0.085
Nodular opacity r =  0.189, p = 0.120 r =  0.202, p = 0.096
Note. GGO = ground-glass opacitythe patients with NSIP were more likely to improve with
treatment than the areas of GGO in the patients with UIP
(13, 16, 17). The GGO areas in NSIP patients corresponded
histopathologically to the areas of interstitial thickening
that are caused by various degrees of interstitial inflamma-
tion or fibrosis (15). However, in our study, the follow-up
CT scans showed no significant differences in the changes
of the extent and pattern of the parenchymal abnormalities
between the NSIP and UIP-w/o hc patients. It should be
noted, however, that the follow up period of the UIP-w/o
hc patients (mean; 711 days, SD; 551) was slightly shorter
than that of the NSIP patients (mean; 939, SD; 703). Our
study also demonstrated that the short-term prognosis of
the NSIP patients was similar to that of the UIP-w/o hc
patients, but it was better than that of the UIP-w/i hc
patients. During the follow-up period, 16 (46%) of the 35
patients with UIP-w/i hc died compared to three (12%) of
the 25 patients with NSIP and five (14%) of the 35
patients with UIP-w/o hc.
The histological distinction between UIP and NSIP can
be difficult. In our study, two expert lung pathologists
disagreed on the diagnosis of UIP vs NSIP in nine of 95
(9%) patients. Furthermore, inter-lobar and intra-lobar
histologic variability is known to be common in idiopathic
interstitial pneumonias. Flaherty et al. (18) have found that
interlobar histologic variability was seen in 26% of the
patients with NSIP and UIP. The concurrent presence of
the histologic UIP and NSIP patterns within the same
patient also raises questions about the pathogenesis and
the nosology of these two disorders. One of the possible
pathogenesis is that NSIP may be an early lesion that
progresses to UIP over time.
Serial changes of the pulmonary function, including the
forced vital capacity and diffusing capacity for carbon
monoxide, have been reported in patients with UIP and
NSIP (16, 19). When comparing the extent of GGO at
presentation with the improvement of the pulmonary
function after corticosteroid treatment in 19 patients with
idiopathic pulmonary fibrosis, Lee et al. (19) found a signif-
icant correlation with the forced vital cavity (r = 0.70) and
the diffusing capacity for carbon monoxide (r = 0.67). Kim
et al. (17) have also reported that the changes in the extent
of the GGO at the follow-up CT correlated well with the
changes in the diffusing capacity for carbon monoxide and
the forced vital capacity in the patients with NSIP. In our
study, the change in the overall extent, GGO, reticulation,
GGO away from the reticulation and consolidation of the
parenchymal abnormalities on HRCT showed a moderate
correlation with the changes in the FVC. However, the
change of all the parenchymal abnormalities except reticu-
lation did not show any correlation with the changes in the
diffusing capacity of CO gas (DLCO) (Table 5). In our
study, the serial changes of the pulmonary function in the
three different groups were different from the HRCT
changes. The follow-up CT scans showed no significant
differences in the changes of the extent and the pattern of
parenchymal abnormalities between the NSIP and UIP-
w/o hc patients. However, the serial changes of pulmonary
function were different between the NSIP and UIP-w/o hc
patients.
Our study has several limitations. First, our estimation of
the extent of the parenchymal HRCT abnormalities was
subjective. This semi-quantitative method may not have
reflected the exact extent of disease. However, our study
showed fair to good agreement between the observers for
the extent of parenchymal abnormalities, except for GGO
away from the reticulation. Second, the follow-up periods
of the UIP-w/o hc patients (mean; 711 days, SD; 551) and
the UIP-w/i hc patients (mean; 484 days, SD; 366) were
relatively shorter than that of the NSIP patients (mean;
939 days, SD; 703). Third, the serial changes of the extent
of the parenchymal HRCT abnormalities and the
pulmonary function may be different between the patients
with and without treatment. The current study included
both the patients with and without treatment. Fourth,
about 10% of the NSIP patients had a predominant
interstitial inflammation histopathology; thus, these
patients had a clearly better prognosis than the remaining
90% of the NSIP patients (7, 14, 20, 21). We included all
the NSIP patients without considering these histopatho-
logic or prognostic distinctions.
In conclusion, the patients with NSIP and UIP-w/o hc
showed quite similar patterns of parenchymal abnormali-
ties at the initial and follow-up CTs, and this was different
from those patterns of the UIP-w/i hc patients, and they
had a better prognosis than the patients with UIP-w/i hc.
Changes in the overall extent, GGO, reticulation, GGO
away from the reticulation and consolidation of the
parenchymal HRCT abnormalities showed moderate
correlation with the changes in the FVC. Long-term,
prospective follow-up studies are needed on the clinical
and radiologic findings of NSIP and UIP; interdisciplinary
and consensus meetings on the radiologic and histopatho-
logic diagnosis are required to document the relationship
between these two disorders.
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